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Abstract  
Introduction: Thyroid gland has the highest selenium content compare with other 
endocrine organs. Enzyme that catalyzing thyroid hormone activation, iodothyronine 
deiodinases, were identified as selenocysteine-containing proteins. Selenium levels in soil 
and rice consumed in Indonesia were lower than in several other countries, which can 
increase the risk of selenium deficiency that has been associated with various type of 
thyroid diseases.  
Methods: This is an article review of the current literatures published up to November 
2018 about the role of selenium in hyperthyroid. 
Result: Several studies have shown that selenium supplementation can be beneficial in 
patients with Graves disease and autoimmune thyroiditis. Selenium has an important 
immunomodulatory effect, but the effects of selenium supplementation in hyperthyroid 
has not been conclude. Data regarding selenium intake, prevalence of deficiency, and the 
relationship between selenium and thyroid disease in Indonesia are limited. Various study 
of selenium supplementation in thyroid disease provide controversial results, so there are 
no guidelines that include selenium as standard therapy hyperthyroid. Selenium 
supplementation can enhance the restoration of biochemical euthyroidism in Graves 
disease and was associated with a significant decrease in the levels of thyroid peroxidase 
antibodies in autoimmune thyroiditis.  
Conclusions: Micronutrients that play a role in thyroid hormone synthesis and maintain 
thyroid function in addition to selenium are iodine, iron, zinc, and vitamin A. By correcting 
the deficit of selenium, and meeting other micronutrient requirements may provide health 
benefits in patient with hyperthyroid. 
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Introduction 
 
Hyperthyroidism or thyrotoxicosis is a clinical 
condition due to inappropriately high synthesis and 
secretion of thyroid hormones by the thyroid gland. 
In the United States, the prevalence of 
hyperthyroidism is around 1.2%; 0.5% overt, and 
0.7% subclinical. The most common cause of 
hyperthyroidism is Grave's disease, toxic 
multinodular goiter, and toxic adenoma.1 Riset 
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Kesehatan Dasar (Riskesdas) 2013 in Indonesia, 
stated that the prevalence of hyperthyroidism in the 
Indonesian population aged 15 years or older was 
0.4% or more than 700,000 persons.2 Thyroid 
abnormalities occur very frequently in the 
population, located around 10-15% of the total 
population.3 
The thyroid is a gland that contains high 
selenium compared to other endocrine organs. 
Selenium in the form of selenoprotein is important 
to maintain thyroid function.4 Selenoproteins 
(glutathione peroxidase and thioredoxin reductase) 
also act as cellular antioxidants and protect the 
thyroid gland from damage caused by hydrogen 
peroxide and reactive oxygen species. The most 
important enzymes and are directly involved in 
thyroid hormone activation, iodothyronin 
deiodinases, are also selenoproteins. Selenium 
deficiency, especially those that occur in 
conjunction with iodine deficiency, will interfere 
with the synthesis and metabolism of thyroid 
hormones and contribute to the incidence of goiter, 
hypothyroidism, and autoimmune thyroid disease. 
Lower selenium levels were observed in newly 
diagnosed Graves disease and autoimmune 
hypothyroidism, but correlations of selenium with 
serum thyroid peroxidase (TPO) and thyroglobulin 
autoantibodies (TgAb) are less consistent. The exact 
molecular, cellular and systemic mechanisms 
contributing to the obvious relationships among Se 
status, iodine availability and handling, and thyroid 
function and the maintenance of its integrity remain 
to be studied.5 
In Indonesia, previous studies was found that 
selenium levels in soil was low, likewise the 
selenium intake and selenium content in rice 
consumed by Indonesian people were lower than 
some other countries, which could increase the risk 
of selenium deficiency.6,7 Selenium is most 
commonly found on the ground and a balanced diet 
should provide enough selenium for thyroid 
hormone synthesis. Selenium deficiency occurs in 
patients with impaired gastrointestinal absorption or 
receiving long-term parenteral nutrition therapy, as 
well as people living in areas where selenium 
content in their soil is very low. Providing selenium 
supplementation is very important in these patients 
to prevent dysfunction of the thyroid.8  
In Graves disease, several studies have 
shown that selenium supplementation can enhance 
the restoration of biochemical euthyroidism.9 
Selenium supplementation has also been shown to 
reduce thyroid peroxidase antibodies (TPOAb) in 
autoimmune thyroiditis.10 Immunomodulatory 
effects of selenium may causing a decrease in the 
release of proinflammatory cytokines,11 but the 
effects of selenium supplementation that clinically 
relevant are still unclear. Research on selenium and 
its relationship to hyperthyroidism in Indonesia is 
still very limited. This paper will explain the role of 
selenium in hyperthyroidism, so that it is expected 
to increase knowledge about micronutrients that 
might help in prevention or therapy.  
 
Hyperthyroidism 
 
Hyperthyroidism or thyrotoxicosis can appear if (i) 
the thyroid is excessively stimulated (Graves 
disease); (ii) constitutive activation of thyroid 
hormone synthesis and secretion, that is cause 
autonomous release of excess thyroid hormone 
(toxic multinodular goitre, solitary toxic nodule, and 
familial non-autoimmune hyperthyroidism); (iii) 
thyroid are released in excessive amounts owing to 
autoimmune, infectious, chemical, or mechanical 
insult; or (iv) there is exposure to extrathyroidal 
sources of thyroid hormone (struma ovarii, 
metastatic differentiated thyroid cancer) or 
exogenous (factitious thyrotoxicosis).1,12  
The common causes of hyperthyroidism are 
Graves disease, toxic multinodular goitre, toxic 
adenoma, and painless thyroiditis. Graves disease is 
an autoimmune disease in which thyroid-stimulating 
antibodies (thyrotropin receptor antibodies, TRAb) 
will activate thyroid-stimulating hormone (TSH) 
receptors and triggering thyroid hormone 
synthesis.1,13 In addition to TRAb, TgAb and 
TPOAb can also be detected in patients with Graves 
disease.14 Risk factors for Graves disease are female 
and personal or family history of an autoimmune 
disorder. Toxic multinodular goitre is the most 
common cause hyperthyroidism in older persons 
who are living in iodine deficient areas. Nodules 
arise from replication of clonogenic cells that leads 
to a mutation of TSH receptors, if a single nodule 
detected, it is called a toxic adenoma.13 Other 
etiology is painless or silent thyroiditis. It is an 
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autoimmune that causes a destruction of thyroid 
follicles and leading to release of preformed thyroid 
hormones into the circulation.15 Gestational 
hyperthyroidism can occur in the first trimester of 
pregnancy. Placental beta human chorionic 
gonadotropin (β-hCG), which shares structural 
features with TSH, has stimulatory action on the 
thyroid gland. β-hCG mediated hyperthyroidism can 
also caused by hyperemesis gravidarum or 
gestational trophoblastic tumor.16 
The clinical manifestations of 
hyperthyroidism ranges from asymptomatic to 
thyroid storm. Increasing of thyroid hormone 
amplify catecholamine signaling through increased 
numbers of beta-adrenergic receptors, and resulting 
adrenergic symptoms (palpitations, heat intolerance, 
diaphoresis, tremor, stare, lid lag, hyper defecation) 
are the most common clinical manifestations of 
hyperthyroidism.10 Despite of an increased 
appetite, hypermetabolism will induces weight loss 
in hyperthyroid patients. Other symptoms that can 
occur are neuromuscular symptoms (weakness of 
proximal muscles), psychiatric symptoms (range 
from anxiety to frank psychosis), atrial fibrillation 
(10% to 15% of patients), or heart failure (5.8% of 
patients).13 
If there is clinical suspicion of 
hyperthyroidism, then laboratory testing should be 
done (Figure 1). Serum TSH has the highest 
sensitivity and specificity for hyperthyroidism. Free 
thyroxine (T4) and total triiodothyronine (T3) levels 
need to be tested if the TSH level is low (free T3 
assays are poorly validated). The physicians can also 
order all three tests in one time to make the diagnosis 
more efficiently. To diagnose Graves disease, serum 
level of thyroid-stimulating immunoglobulins or 
TSH receptor antibodies helps distinguish from 
other causes of hyperthyroidism in patients who lack 
clinical signs and symptoms of Graves disease that 
pathognomonic and have a contraindication to 
radioactive iodine uptake and scan.13  
 
 
 
 
Figure 1. Algorithm for hyperthyroidism diagnosis 
T3, triiodothyronine; T4, thyroxine; TSH. thyroid-stimulating hormone 
Source: reference no 13 
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Metabolism, Daily Requirement, and Food 
Sources of Selenium 
 
Selenium is a micronutrient that was first discovered 
in 1817. Selenium from the Greek, would be the 
“moon”, because selenium a sheen similar to that of 
the moon.17 Selenium is available both in organic 
compounds (selenomethionine and selenocysteine) 
and inorganic compounds (selenite and selenate).18 
Selenium is present in food especially in organic 
forms, and probably absorbed in the small intestine 
especially by transcellular diffusion. The inorganic 
form of selenium, which is selenite or selenate are 
only found in small amounts in foodstuffs. There is 
a difference in absorption efficiency and 
bioavailability of selenium depending on the form 
(selenomethionine > selenocysteine > selenate > 
selenite).19 The biological activity of selenium 
depends on absorption, retention, and excretion. 
Selenomethionine is absorbed more quickly and 
completely (98%) than sodium selenite (84%) and 
uptake by the liver occurs faster after administration 
of organic selenium rather than inorganic. In 
addition, selenomethionine is excreted less than 
sodium selenite, faecal excretion: 4 versus 18%, 
urinary excretion: 11 versus 17%, and total 
excretion: 15 versus 35%. Selenomethionine is 
retained in the body for 363 days, while sodium 
selenite 147 days, this slower turnover allows an 
efficient reutilization of selenomethionine. Because 
of these properties, high doses of selenomethionine 
or uncontrolled long-term supplementation should 
be avoided because this can cause tissue 
accumulation and selenium toxicity.17 In other 
studies, increased selenite absorption occurs when 
given together with glutathione rather than given 
alone, this is probably due to to formation of 
selenodiglutathione, which may be absorbed 
differently from selenite.20 Selenium excretion is 
mostly via urine (in the form of selenosugars and 
methylated as trimethylselenonium) which is about 
60% of total excretion of selenium, 35% is excreted 
through feces, and in small amounts excreted 
through sweat, breathing, and saliva.21,22 
Recommended dietary allowance of 
selenium in America and from European 
Commission (Scientific Committee on Food) for 
both male and female adults is 55 mcg/day. In 
United Kingdom and Belgium, recommendation for 
selenium intake is between 60-75 mcg/day. Based 
on the World Health Organization/Food and 
Agriculture Organization/International Agricultural 
Exchange Association, recommendation of 
selenium intake is only 40 mcg/day in men and 30 
mcg/day in women.6 The maximum 
recommendation of selenium based on the World 
Health Organization is 400 mcg/day, and the 
minimum intake is 10 mcg/day.7 
Data of selenium intake and selenium 
content in food ingredients in Indonesia are very 
limited. The study of Untoro et al.23 in East Java 
showed that selenium content in egg yolks (0.15-
1.52 mcg/g) and egg white (0.2-2.97 mcg/g) were 
lower than 1 mcg/g, and that values are below the 
data from Belgium, Venezuela, and Chile. Eggs 
contribute about 8% of the estimated daily selenium 
intake (50 mcg/day for healthy adults).23 In a study 
in Bandung that assess selenium levels in rice as the 
main staple food consumed by populations, the 
results showed that the mean selenium levels in rice 
consumed were 0.035 mcg/g, lower than other 
countries, as can be seen in Figure 2.6 In another 
study in East Java, it was found that the mean 
selenium levels in the soil in the area of the goitre 
group were lower compared to the control group, 
respectively 3.2 and 4.6 mcg/kg, but not 
significantly different.24 The most recent study 
showed that selenium levels in the soil in Indonesia 
is around 0.24-1.31 mg/kg of soil, with the highest 
content in the Papua area, and the lowest found in 
Kalimantan area, as can be seen in Table 1.7  
Until now it is still unknown the reference 
values of selenium levels that can be use as a 
parameters to detect the risk of disease caused by 
selenium deficiency.25 Large studies are limited 
because it is difficult to estimate selenium intake 
from questionnaires due to significant variations of 
selenium content in the same food ingredients. 
Measuring the content of selenium in food 
ingredients is also limited due to the large 
geographic variability.26 Food source of selenium 
and its content can be seen in Table 2.27 
The greatest selenium concentration (>1 
mg/kg) was found in Brazil nuts and offal.28 In 
Europe, the average daily intake of selenium is 
estimated at 40 mcg/day (range 32-62 mcg/day), 
whereas in America it is 93 mcg/day in women and 
134 mcg/day in men.1 The mean selenium intake in 
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diabetic patients in several hospitals in Bandung was 
74.62 ± 15.46 mcg/day, with a minimum intake was 
41 mcg and a maximum was 104 mcg.29 
The content of selenium in vegetables can be lost 
during processing and cooking. Refining grains also 
will reduce selenium content by 50-75%, while 
boiling can reduce 45% selenium.30 There are 
differences in the retention and distribution of 
selenium derived from broccoli or beef / pork, but 
administer of foods that is containing high selenium 
(1.5 mcg selenium/gram diet) did not cause 
significant changes in selenium bioavailability 
compared to adequate amounts (0.1 mcg 
selenium/gram diet).31   
 
Selenium Function in Thyroid Gland 
Selenium is work actively in the form of 
selenocysteine amino acids known as a group of 
proteins known as selenoproteins. The main 
selenoprotein group is glutathione peroxidase 
(GPx), thioredoxin reductase (TXNRD), and 
iodothyronine deiodinase (DIO) as can be seen in 
Table 3.17 GPx which have oxidoreductase function 
and also regulates immune response, it is plays a role 
in the defense system of the cell against reactive 
oxygen species and maintains lipid constituents of 
cell membranes.25 TXNRD can modulate 
transcription and signal transduction functions. DIO 
which catalyzes the conversion of T4 to T3, and rT3 
which are very important for thyroid hormone 
metabolism.17 Although glutathione peroxidase acts 
in neutralizing oxidants, other antioxidants such as 
vitamin E and vitamin C, and Vitamin B2 which is 
needed by the glutathione reductase also plays a role 
in synergistic action in oxidative stress 
neutralization.32,33 
 
 
Figure 2. Comparison chart levels of selenium in raw rice or cooked rice in some countries 
Source: reference no6 
 
Table 1. Selenium concentration in the soil and rice by location in Indonesia 
Area Selenium 
 Soil Rice 
Papua 1.31±0.07  0.068±0.0015 
Lampung 1.25±0.08  0.101±0.0059 
Kalimantan 0.18±0.03  0.007±0.0012 
Java 0.44±0.11  0.022±0.0040 
Bali 0.24±0.03  0.007±0.0040 
Sulawesi 0.24±0.03  0.024±0.0006 
Source: reference no 7 
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Selenoprotein P (SEPP) is a source of more than Table 2. Food sources and content of selenium 
Food Source mcg/portion %needs/day 
Brazil nuts, 1 ounce (6-8 nuts) 544 777 
Tuna, yellow fin, cooked, dry heat, 3 ounces 92 131 
Halibut, cooked, dry heat, 3 ounces 47 67 
Sarden, canned in oil, dried with bone, 3 ounces 45 64 
Ham, baked, 3 ounces 42 60 
Shrimp, canned, 3 ounces 40 57 
Steak, grilled, 3 ounces 33 47 
Cow liver, pan fried, 3 ounces 28 40 
Chicken, thigh, grilled, 3 ounces 22 31 
Brown rice, cooked, 1 cup 19 27 
Minced meat, 25% fat, grilled, 3 ounces 18 26 
Egg, cooked, 1 egg 15 21 
Wheat bread, 1 slice 13 19 
Oatmeal cooked with water, 1 cup 13 19 
Spinach, frozen, boiled, 1 cup 11 16 
Milk, 1% fat, 1 cup 8 11 
Yogurt, plain, low fat, 1 cup 8 11 
White bread, 1 slice 6 9 
Banana, 1 cup 2 3 
Potato, baked, with skin, 1 piece 1 1 
Carrot, raw, 1 cup 0 0 
Source: reference no 27 
Table 3. Main selenoproteins and their function that are found in the thyroid gland 
Selenoproteins Abbreviation Function 
Glutathione peroxidase  GPX Catalyzes the reduction of H2O2; Protects against oxidative 
stress 
Cytosolic GPx1  GPX1 Antioxidative defence 
Extracellular GPx  GPX3 Anti-inflammatory action 
Phospholipid GPx  GPX4 Reduces the phospholipids’s hydroperoxides; Regulates 
apoptosis 
Iodothyronine 
deiodinase 
DIO Catalyzes the conversion of T4 and T3 
Type I DIO  DIO1 Conversion T4 to T3 
Type II DIO  DIO2 Local production (intracellular) of T3 from T4 
Type III DIO  DIO3 Production of rT3 from T4, and T2 from T3 
Thioredoxin reductase TXNRD Oxidoreductase activity having the NADPH as a cofactor 
TXNRD cytosolic  TXNRD1 Main antioxidant ‘‘weapon’’ at the cellular level 
TXNRD mitochondrial TXNRD2 Regulates cell proliferation 
Selenoprotein P  SEPP Selenium transporter 
Selenoprotein K  SELK Endoplasmic reticulum-associated degradation and immune 
response 
Selenoprotein N  SEP15 Degradation of H2O2 
Selenoprotein S  SELS Transmembrane protein, putative role in endoplasmic reticulum 
stress 
Selenoprotein T  SELT Calcium mobilization 
Selenoprotein V  SELV Testes-specific expression 
Selenoprotein W  SELW Antioxidant role 
NADPH = nicotinamide adenine dinucleotide phosphate (reduced form of the redox coenzyme nicotinamide adenine 
dinucleotide phosphate) 
Source: reference no 17 
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Selenoprotein P (SEPP) is a source of more than 
50% plasma selenium, which is the main plasma 
transport and distribution system of selenium. 
SEPP circulates in various forms with different 
glycosylation patterns. SEPP is produces by 
hepatocytes and it is very important for maintaining 
selenium homeostasis as it sustains retention of 
selenium in the body and increase distribution from 
the liver to other tissues, especially in selenium 
deficiency.34 Inactivation of the SEPP gene in mice 
actually reduces selenium content in the plasma, 
kidneys, testis, brain, and the activity of 
selenoenzyme in various organs drastically.35 SEPP 
deficiency can actually trigger neurological 
disorders (ataxia and seizures), indicating an 
important role of SEPP to transport selenium in the 
brain.36 The thyroid affects the mRNA levels of 
several enzymes involved in selenoprotein 
biosynthesis and SEPP concentrations, suggesting 
that the thyroid hormones can have a positive effect 
on serum selenium status and regulates the 
expression of several selenoproteins. Recent data 
show that single-nucleotide polymorphisms in 
selenoproteins can increase selenium utilization 
and effectiveness.17 
Selenium also has the ability to increase T 
cell activity and cytotoxicity from natural killer 
cells, so that it may be effective in viral infections. 
17 Selenium supplementation can stimulate the 
immune system by increasing the differentiation of 
CD4 + cells into T helper (Th) 1 cells, enhance 
expression of interleukin-2 and also lymphocyte 
proliferation.37  This effect might be effective to 
eradicated the virus that considered to be involved in 
autoimmune thyroid diseases.38 Further, selenium 
supplementation can also reduce production from 
CD4+ CD25+ T cells by increasing the regulation of 
forkhead box P3 (FOXP3) expression and 
increasing the percentage of regulatory T cells, 
thereby suppressing excessive inflammation.11 This 
studies showed that selenium might have reduce the 
excessive immune responses in autoimmune thyroid 
disease. 
 
Selenium in Hyperthyroidism 
 
In the thyroid gland, selenium concentration is very 
high (0.2-2 mcg/g). In adults, selenium 
concentration in the thyroid gland (0.72 ± 0.44 
mcg/g) was significantly higher than in liver (0.45 ± 
0.11 mcg/g).39 The association of selenium with the 
functioning of DIO was identified as an enzyme 
containing selenocysteine, and DIO activity 
depending on selenium availability. Thyrocytes 
produce hydrogen peroxide (H2O2), which is 
important for the activity of TPO and iodide 
oxidation.17 The formation of H2O2 is regulated 
through the action of TSH via a complex network of 
second-messenger systems. The iodination of 
thyroglobulin and formation of H2O2 occur on the 
apical membrane of the thyrocyte. The H2O2 formed 
on the surface of the thyrocyte are available for 
iodination of thyroglobulin.40 H2O2 will be reduced 
to H2O, but if H2O2 is present in large quantities, it 
will cause radical oxygen species damage.41 In the 
process of thyroid hormone synthesis, GPX1, 
GPX3, and TXNRD1 up-regulated, and by acting as 
antioxidants and modifying redox status, they can 
protect the thyroid from peroxidation damage. 5,17 In 
hyperthyroidism, there is significantly increased of 
malondialdehyde (MDA) levels in erythrocytes, 
plasma, and urine patients.42 Selenoprotein protects 
the thyrocyte from oxidative damage and modulates 
thyroid hormone biosynthesis, so it is crucial for 
maintaining the function and integrity of the thyroid 
gland, although it might not be essential for survival 
of the thyrocyte.5,17 
Selenium supplementation (even in non-
deficient subjects) can induce immune stimulatory 
effects such as an increase in the number of activated 
T lymphocytes and regulates of Th1/Th2 cytokine 
expression.43 Combined iodide and selenium 
deficiency can cause H2O2 accumulation; selenium 
deficiency can reduced cell defense, increasing 
transforming growth factors β, and fibrosis of 
thyroid tissue. This will cause thyroid 
destruction.44,45 In iodine and selenium deficiency, 
selenium supplementation can aggravate 
hypothyroidism due to stimulation of thyroxine 
metabolism by DIO type I, so selenium 
supplementation is not indicated without iodine 
supplementation or thyroid hormone.46 
In euthyroid healthy subjects with marginal 
selenium deficiency, selenium supplementation has 
little and no clinically significant effect on thyroid 
function.47 From previous studies it was found that 
selenium levels were inversely related to thyroid 
size, 48 and several diseases that might have an effect 
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on Selenium supplementation is Graves disease and 
autoimmune thyroiditis. 49  
 
Selenium in Graves Disease 
 
In a study by giving of 300 mcg/day of selenium 
supplementation, it was increasing levels of serum 
selenium and SPP significantly compared to 
placebo. The serum level of fT3, TRAb, and TPOAb 
were markedly lower in subject who received 
selenium supplementation for 24 weeks. Serum 
levels of SPP correlated with serum selenium and 
TSH, but negatively correlated with serum fT3 and 
TPOAb. Serum selenium levels negatively 
correlated with serum TPOAb. This results indicated 
that SPP was the more meaningful biomarker of 
selenium status rather than serum selenium. 
Although there were a significant increase of the 
serum levels of selenium and SPP in the selenium 
group, it did not increase the response or decrease 
the recurrence rate. There were no significant 
differences between two groups pertaining to 
efficacy and clinical course of the thyroid disease. 
The results obtained in the above study support that 
there is a relationship between Grave's disease and 
selenium status, because selenium and SPP 
concentrations are negatively related to TPOAb, and 
SPP is positively associated with serum TSH.11  
Previous study by Leo, et al.50 there was an 
increase in serum selenium levels after 
supplementation 166 mcg/day for 45 days without a 
difference in serum fT3, fT4, and MDA levels 
compared to the control group. In this study, the 
research subjects were selenium-sufficient. From 
the results of this study concluded that selenium 
supplementation does not provide short-term 
benefits in hyperthyroidism, but may be useful in 
patients with selenium deficiency, so it is necessary 
to evaluate the selenium status of patients before 
giving antithyroid therapy, to assess whether the 
patient might get beneficial effects from selenium.50 
The study by Calissendorff et al.37 in patients 
Graves thyrotoxicosis was found that fT4 levels 
decreased more in the selenium supplementation 
(200 mcg/day) group after 18 and 36 weeks, and 
increase TSH levels after 18 weeks. The 
concentration of SPP also increased in the selenium 
group. FT4 and TSH might imply a reduction in 
disease activity in patients with Graves disease with 
the addition of selenium. There was no change in 
TRAb levels in the two groups probably due to other 
indirect mechanisms. Some factors could be 
mediated by the immune system, by effects on 
oxidative stress in the thyroid gland or by deiodinase 
enzymes. Selenium is important for initiation and 
enhancing immunity, but it is also being involved in 
the regulation of excessive immune responses. This 
is very important to prevent responses that can lead 
to autoimmunity or chronic inflammation.37 
Selenium supplementation also has a stimulating 
effects on the immune system by promote the 
differentiation of CD4 + cells into Th1 cells.51 The 
supplementation of selenium also shows an 
association between enhanced expression of 
interleukin-2 receptors and lymphocyte 
proliferation, but whether the immune system can be 
modulated through selenium in Graves disease 
remains speculative. In this study there were no 
significant changes in TRAb or TPOAb during 
selenium supplementation.37 Serum selenium levels 
that increased significantly in selenium 
supplementation were not accompanied by 
decreased levels of autoantibodies, indicating a lack 
of adjuvant effects of selenium supplementation in 
antithyroid treatment. These results were contrary to 
Hashimoto's thyroiditis disease, where there was a 
decrease in TPOAb after selenium.52 Selenium did 
not appear to affect immunoglobulins in Graves 
disease.37 
The results of meta-analysis of selenium 
supplementation can enhance the restoration of 
biochemical euthyroidism and might be useful in 
Graves disease with selenium deficiency.9,49 
Positive results of the study should be carried out in 
a larger methodology study before selenium can be 
included in international guidelines as standard 
therapy.9 European Group On Graves Orbitopathy 
(EUGOGO) provides selenium supplementation in 
mild and inactive Graves orbitopathy patients in 
initial management.53 This is due to the potential 
efficacy of supplementation 200 mcg/day selenium 
for 6 months in Graves Orbitopathy. Giving 
selenium supplementation was significantly 
improves quality of life, reduces ocular 
involvement, and slows disease progression in 
patients with mild Graves orbitopathy.54 
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Selenium in Autoimmune Thyroiditis 
 
In patients with euthyroid autoimmune thyroiditis, 
supplementation of 166 mcg selenium/day for 6 
months did not changes concentrations of TSH, fT4, 
fT3, TPOAb, thyroid echogenicity, and CXCL-10 
(chemotactic cytokines that seems to have a major 
role in thyroid autoimmunity) levels compared to the 
control group. Short-term selenium supplementation 
has a limited effect on euthyroid autoimmune 
thyroiditis patients. In this study, there was an 
increase in fT3 levels and a decrease in fT4 in the 
group given selenium, but not in the control group 
after 3 and 6 months. This may be due to an 
increased action of deiodinase induced by L-
selenometionin.55  
This study is different from the results 
obtained by Nacamulli et al.10 that 80 mcg selenium 
supplementation/day may be effective in preventing 
a decrease in thyroid echogenicity and reducing 
levels of TPOAb and TgAb, although there were no 
changes in TSH and fT4 levels for 12 months. This 
difference in results may be due to differences in the 
timing of selenium supplementation associated with 
low selenium intake. The study area where the study 
subjects lived only had soil with lower selenium 
levels.55 Another study with selenomethionine 80 
mcg and 160 mcg for 12 months in euthyroid 
autoimmune thyroiditis patients did not provide 
changes in TPOAb levels, but there was a significant 
increase in TPOAb in the group who got a placebo. 
This shows the potential for selenium effects to 
protect the progression of the disease in 
selenomethionine supplementation.56  
Other studies showed a significant reduction 
in TPOAb levels after 3 months supplementation of 
200 mcg selenomethionine/day.57 Chemokine 
CXCL-9 levels decreased significantly after 12 
months supplementation of 80 mcg of 
selenomethionine/day, whereas with 
supplementation 160 mcg selenomethionine/day, a 
significant decrease was seen in the 6 month and 
remain stable. CXCL-10 levels decreased 
significantly after 12 months of supplementation 
both in the group that given selenomethionine 80 
mcg and 160 mcg. The chemokines are involved in 
the pathogenesis of autoimmune thyroiditis. The 
results of that study showed a positive effect of 
selenomethionine as an immunomodulator by 
reducing some cytokine regulation.56  
Study by Farias et al.52 showed a decrease in 
TPOAb by giving selenium supplementation for 3 
months that occurred after 6 months. Low selenium 
levels are associated with poor immune function, 
and it has been hypothesized that mild selenium 
deficiency may promote the progression of thyroid 
autoimmunity. Selenium supplementation is 
associated with decreased levels of serum 
concentration of thyroid autoantibodies and 
stabilized the autoimmune response in various 
variables in different studies and different groups of 
patients.52 The decreases in TPOAb may be due to 
an increase in intra-thyroid selenium levels that will 
reduce reactive oxygen species damage through 
enhanced expression of glutathione peroxidase and 
improvement of redox status in thyrocyte through 
increasing thioredoxin reductase activity. Selenium 
supplementation may also reduce the production of 
CD4 + CD25 + T cells by up-regulating of Fox3p 
mRNA and increasing the percentage of T 
regulatory cells, which will decrease some immune 
responses and restore them to approach normal 
levels. Selenium requirements are not only 
influenced by selenium status, but also by 
selenoprotein gene polymorphisms including SEPP, 
therefore it is better to rule out the presence of gene 
polymorphisms before drawing conclusions about 
activity of selenoprotein in response to therapy. The 
positive effects of selenium supplementation on 
chronic thyroiditis autoimmune are obtained both in 
deficiency and adequacy due to pharmacologic 
activity.52 
Meta-analysis by Toulis et al.58 found that 
supplementation 200 mcg selenium/day in chronic 
autoimmune thyroiditis was associated with a 
decrease in concentration of TPOAb within 3 
months. Other systematic reviews of 4 studies 
showed that supplementation of 200 mcg 
selenium/day of in chronic autoimmune thyroiditis 
gave positive and statistically significant results, but 
the study have a high risk of bias, so evidence to 
support the efficacy of Hashimoto's thyroiditis is not 
reliable enough to help make clinical decisions.59 
The latest meta-analysis informs that there have 
been conflicting reports regarding selenium 
supplementation in autoimmune thyroiditis patients. 
With current evidence it is not possible to justify 
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selenium supplementation in autoimmune 
thyroiditis patients, but correcting of a selenium 
deficit might provide other health benefits.60  
Micronutrients that contribute to thyroid 
hormone synthesis and maintain thyroid function 
other than selenium is iodine, iron, zinc, and vitamin 
A.8 Study by Guerra et al.42 in Graves disease 
patients who were given methimazole and 
supplemented with antioxidant mixture (200 mg 
vitamin E, 3 mg β-carotene, 250 mg vitamin C, 1 mg 
Cu, 7.5 mg Zn, 1.5 mg Mn, and 15 mcg Se) 
associated with a better biochemical and clinical 
control of hyperthyroidism in patients given this 
mixture compared with methimazole alone. In this 
study, they only gave a small amount of selenium 
(15 mcg), but patients receiving the antioxidant 
mixture showed a significant improvement in their 
clinical score after the first 4 week. Methimazole 
and the antioxidant mixture affected both urinary 
and serum malondialdehyde contents.42 In other 
study, the fT4 and fT3 levels decreased more rapidly 
in Graves disease patients who received 
methimazole, antioxidants and 60 mcg selenium 
compared to methimazole alone after 30 and 60 
days. In the group receiving antioxidants there is 
also significant increase of TSH after 60 days. 61 
This may be due either to the other antioxidative 
components (vitamin C, vitamin E, and β-carotene) 
or to selenium given in that study.  
Conclusion 
Selenium is a micronutrient that needed only in a 
small quantities by the human body. Amount of 
selenium in food ingredients depends on the content 
of selenium in the soil. Studies on selenium levels, 
intake, and prevalence of selenium deficiency in 
Indonesia are very limited. In Indonesia, some 
studies showed that selenium in the soil were low, 
which might increase risk of selenium deficiency. 
Selenium has an important function in various 
metabolisms in the body, especially in the thyroid 
gland. Selenium works in its active form, namely 
selenocysteine which is known in the selenoprotein 
group. Glutathione peroxidase, thioredoxin 
reductase, and iodothyronine deiodinase are the 
main selenoproteins that play a role in maintaining 
the function and regulation of the thyroid gland 
through antioxidant mechanisms, regulation of 
immune responses, and signal transcription and 
transduction. 
In hyperthyroidism, the administrations of 
selenium as supplementation were have different 
results and the benefits that are clinically relevant 
are still unclear. Selenium supplementation may 
improve biochemical hormone in patients with 
Graves' disease with selenium deficiency, whereas 
in mild inactive Graves orbitopathy, selenium 
supplementation might be beneficial. In several 
studies in patients with autoimmune thyroiditis, it 
was found that selenium supplementation can reduce 
autoimmune antibodies, but from the results of 
existing studies, it cannot be concluded that 
selenium supplementation can have a positive effect. 
Perhaps the administration of selenium in 
hyperthyroid patients with selenium deficiency can 
provide health effects, accompanied by meeting the 
needs of other micronutrients that play a role in 
maintaining the thyroid function such as iodide, 
iron, zinc, and vitamin A. The exact molecular, 
cellular, and systemic mechanisms contributing to 
the obvious relationships among selenium status and 
thyroid function and the maintenance of its integrity 
remain to be studied. Further research is needed on 
the role of selenium in hyperthyroid patients, 
selenium levels in various foods in Indonesia, as 
well as the prevalence of selenium deficiency to 
determine whether selenium supplementation 
should be given, especially in autoimmune 
hyperthyroid patients 
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